People · Operator
Named in public records as an officer, director or promoter · active 2017–2017 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Integrated Nano-Technologies, Inc. | — | Biotechnology | Series A | $6.3M | $227.8M | 2017 |
Yuichiro J. Morimoto at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Yuichiro J. Morimoto on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| J. Michael Holloway | 1 | 2 |
| David R. Franz, DVM, Ph.D. | 1 | 2 |
| JOHN J. HAMRE | 1 | 2 |
| Dennis M. Connolly, Jr. | 1 | 2 |
| Robert N. Latella | 1 | 2 |
| Gen. Dennis J. Reimer | 1 | 2 |
| Dennis M. Connolly, Sr. | 1 | 2 |
| John M. Noonan | 1 | 2 |
| Ronald C. Austin | 1 | 1 |
| Yoichi J. Takeuchi | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.